| 000 | 01540 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250517180132.0 | ||
| 264 | 0 | _c20171211 | |
| 008 | 201712s 0 0 eng d | ||
| 022 | _a1097-6787 | ||
| 024 | 7 |
_a10.1016/j.jaad.2017.08.017 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGordon, Kenneth B | |
| 245 | 0 | 0 |
_aPoor early response to methotrexate portends inadequate long-term outcomes in patients with moderate-to-severe psoriasis: Evidence from 2 phase 3 clinical trials. _h[electronic resource] |
| 260 |
_bJournal of the American Academy of Dermatology _cDec 2017 |
||
| 300 |
_a1030-1037 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Validation Study | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aDermatologic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMethotrexate _xtherapeutic use |
| 650 | 0 | 4 | _aModels, Statistical |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 |
_aPsoriasis _xdrug therapy |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aBetts, Keith A | |
| 700 | 1 | _aSundaram, Murali | |
| 700 | 1 | _aSignorovitch, James E | |
| 700 | 1 | _aLi, Junlong | |
| 700 | 1 | _aXie, Meng | |
| 700 | 1 | _aWu, Eric Q | |
| 700 | 1 | _aOkun, Martin M | |
| 773 | 0 |
_tJournal of the American Academy of Dermatology _gvol. 77 _gno. 6 _gp. 1030-1037 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jaad.2017.08.017 _zAvailable from publisher's website |
| 999 |
_c27646187 _d27646187 |
||